Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a

Conclusions. These studies illustrate the promise of RBV plus IFN alfa as a potential therapeutic strategy for the treatment of CHIKV infections.

Source: The Journal of Infectious Diseases - September 22, 2016 Category: Infectious Diseases Authors: Gallegos, K. M., Drusano, G. L., D'Argenio, D. Z., Brown, A. N. Tags: VIRUSES Source Type: research